Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 12/20 | 0.69 |
| ▸ | LMNA | P02545 | 10/20 | 0.65 |
| ▸ | HTT | P42858 | 7/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.48 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.45 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.45 |
| ▸ | ATM | Q13315 | 1/20 | 0.45 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | NPC1 | O15118 | 6/20 | 0.43 |
| ▸ | SLC2A1 | P11166 | 5/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 4/20 | 0.43 |
| ▸ | MEN1 | O00255 | 3/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | PAX8 | Q06710 | 2/20 | 0.43 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.43 |
| ▸ | NR2F2 | P24468 | 2/20 | 0.42 |
| ▸ | S1PR2 | O95136 | 2/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14155578 | 0.80 | RAB9A (0.49) | RAB9ALMNAHTTSMN1; SMN2PABPC1 | |
| SCHEMBL19549042 | 0.75 | RAB9A (0.45) | RAB9ALMNAHTTSMN1; SMN2PABPC1 | |
| SCHEMBL10252513 | 0.75 | RAB9A (0.55) | RAB9ALMNAHTTSMN1; SMN2PABPC1 | |
| SCHEMBL1459437 | 0.72 | CA1 (0.71) | RAB9APABPC1APOBEC3AATMAPOBEC3G | |
| SCHEMBL14157802 | 0.71 | CA1 (0.71) | RAB9APABPC1ATMKDM4ENPC1 | |
| SCHEMBL25733711 | 0.70 | RAB9A (0.46) | RAB9ALMNAHTTSMN1; SMN2PABPC1 | |
| SCHEMBL19271266 | 0.70 | FABP4 (0.52) | RAB9AKDM4EMEN1KMT2AALDH1A1 | |
| SCHEMBL19271262 | 0.70 | RAB9A (0.51) | RAB9ALMNAHTTPABPC1APOBEC3A | |
| SCHEMBL19271302 | 0.69 | RAB9A (0.42) | RAB9ALMNAHTTSMN1; SMN2PABPC1 | |
| SCHEMBL19271274 | 0.69 | HSD17B10 (0.64) | RAB9ALMNAHTTSMN1; SMN2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260138121-A1 | SUPPORTED NICKEL-COPPER CATALYST FOR DEHYDROGENATION AND HYDROGENATION OF LIQUID ORGANIC HYDROGEN CARRIERS | CHEVRON U S A INC (US) | 2026-05-21 | — | — | US | disclosed |
| EP-4601788-A1 | CATALYST SYSTEM AND METHOD FOR CATALYTICALLY DEHYDRATING A HYDROGEN CARRIER MATERIAL, REACTOR ARRANGEMENT WITH SUCH A CATALYST SYSTEM AND METHOD FOR PRODUCING SUCH A CATALYST SYSTEM | HYDROGENIOUS LOHC TECHNOLOGIES GMBH (DE) | 2025-08-20 | — | — | EP | disclosed |
| US-12269018-B2 | Platinum-sulfur-based shell catalyst, production and use thereof in the dehydrogenation of hydrocarbons | CLARIANT INTERNATIONAL LTD (CH) | 2025-04-08 | — | — | US | disclosed |
| US-20250065311-A1 | SULFIDATED NOBLE METAL ON METAL DOPED SUPPORT AS A HYDROGENATION AND DEHYDROGENATION CATALYST | CHEVRON USA INC (US) | 2025-02-27 | — | — | US | disclosed |
| WO-2025042907-A1 | SULFIDATED NOBLE METAL ON METAL DOPED SUPPORT AS A HYDROGENATION AND DEHYDROGENATION CATALYST | CHEVRON U.S.A. INC. (US) | 2025-02-27 | — | — | WO | disclosed |
| WO-2024078958-A1 | CATALYST SYSTEM AND METHOD FOR CATALYTICALLY DEHYDRATING A HYDROGEN CARRIER MATERIAL, REACTOR ARRANGEMENT WITH SUCH A CATALYST SYSTEM AND METHOD FOR PRODUCING SUCH A CATALYST SYSTEM | HYDROGENIOUS LOHC TECHNOLOGIES GMBH (DE) | 2024-04-18 | — | — | WO | disclosed |
| US-11905252-B2 | Compounds | INFLAZOME LIMITED (IE) | 2024-02-20 | — | — | US | disclosed |
| CN-111989156-B | Shell catalyst based on platinum-sulphur, production and use in hydrocarbon dehydrogenation | 科莱恩国际有限公司 | 2023-08-11 | — | — | CN | disclosed |
| US-20210347737-A1 | NOVEL COMPOUNDS | INFLAZOME LIMITED (IE) | 2021-11-11 | — | — | US | disclosed |
| US-20210077984-A1 | PLATINUM-SULFUR-BASED SHELL CATALYST, PRODUCTION AND USE THEREOF IN THE DEHYDROGENATION OF HYDROCARBONS | CLARIANT INTERNATIONAL LTD (CH) | 2021-03-18 | — | — | US | disclosed |
| EP-3781307-A1 | PLATINUM-SULFUR-BASED SHELL CATALYST, PRODUCTION AND USE THEREOF IN THE DEHYDROGENATION OF HYDROCARBONS | Clariant International Ltd (CH) | 2021-02-24 | — | — | EP | disclosed |
| CN-111989156-A | Platinum-sulfur based shell catalysts, their production and use in the dehydrogenation of hydrocarbons | 科莱恩国际有限公司 | 2020-11-24 | — | — | CN | disclosed |
| WO-2019201706-A1 | PLATINUM-SULFUR-BASED SHELL CATALYST, PRODUCTION AND USE THEREOF IN THE DEHYDROGENATION OF HYDROCARBONS | CLARIANT INTERNATIONAL LTD (CH) | 2019-10-24 | — | — | WO | disclosed |
| US-10359409-B2 | Method for measuring a degree of hydrogenation | Friedrich-Alexander-Universität Erlangen-Nürnberg (DE) | 2019-07-23 | — | — | US | disclosed |
| US-20170322192-A1 | METHOD FOR MEASURING A DEGREE OF HYDROGENATION | HYDROGENIOUS LOHC TECHNOLOGIES GMBH (DE) | 2017-11-09 | — | — | US | disclosed |
| US-20150239839-A1 | PROCESS FOR PHOTOCATALYTIC ACCEPTOR-FREE DEHYDROGENATION OF HYDROCARBAZOLES AND HYDROINDOLES | EVONIK INDUSTRIES AG (DE) | 2015-08-27 | — | — | US | disclosed |
| US-20150239839-A1 | PROCESS FOR PHOTOCATALYTIC ACCEPTOR-FREE DEHYDROGENATION OF HYDROCARBAZOLES AND HYDROINDOLES | EVONIK INDUSTRIES AG (DE) | 2015-08-27 | — | — | US | disclosed |
| EP-2910546-A1 | Method for the photocatalytic acceptor-free dehydrogenation of hydrocarbazoles and hydroindoles | Evonik Degussa GmbH (DE) | 2015-08-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11905252-B2 | Compounds | NLRP3, NOD1, PYCARD | RAB9A 3000/4885LMNA 809/4885HTT 762/4885 |
| US-20260138121-A1 | SUPPORTED NICKEL-COPPER CATALYST FOR DEHYDROGENATION AND HYDROGENATION OF LIQUID ORGANIC HYDROGEN CARRIERS | NUDC, SOD1, TIMM10 | RAB9A 1861/4885LMNA 3374/4885HTT 744/4885 |
| US-20210347737-A1 | NOVEL COMPOUNDS | NOD1, NLRP3, NOD2 | RAB9A 3156/4885LMNA 1017/4885HTT 781/4885 |
| US-20150239839-A1 | PROCESS FOR PHOTOCATALYTIC ACCEPTOR-FREE DEHYDROGENATION OF HYDROCARBAZOLES AND HYDROINDOLES | HRH3, AHR, HRH4 | RAB9A 3180/4885LMNA 4477/4885HTT 1024/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.